We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Among patients aged at least 85 years who underwent PCI, use of
drug-eluting stents produced better outcomes compared with bare-metal stents,
including lower rates of mortality, despite an overall decline of DES use in
that age group.
The study included 471,006 patients from the CathPCI Registry of the
National Cardiovascular Data Registry who were at least 65 years of age and
underwent PCI between 2004 and 2008. These patients were matched to Medicare
fee-for-service data.
From 2005 to 2008, the population of patients at least 85 years of age
increased in both elective PCI (7% to 9%) and acute PCI (10% to 13%;
P<.001 for both) groups; however, researchers also reported that DES
use decreased with age.
Overall, use of DES was associated with lower rates of mortality in
those at least 85 years of age (adjusted HR=0.80; 95% CI, 0.77-0.83); age 75 to
84 years (adjusted HR=0.77; 95% CI, 0.75-0.79); and age 65 to 74 years
(adjusted HR= 0.73; 95% CI, 0.71-0.75). Risk of rehospitalization for MI was
also significantly lower among DES vs. BMS patients, with the greater risk
reported with increasing age (P<.001).
For More Information:
Wang TY. J Am Coll Cardiol.
2012;59:105-112.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.